| F-18-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy |
13 |
| Lu-177-DOTATATE therapy in patients with neuroendocrine tumours including high-grade (WHO G3) neuroendocrine tumours: response to treatment and long-term survival update |
12 |
| F-18-fluorodeoxyglucose positron-emission tomography combined with computed tomography as a diagnostic tool in native valve endocarditis |
11 |
| Can SUVmax values of Ga-68-PSMA PET/CT scan predict the clinically significant prostate cancer? |
11 |
| Choline PET/CT in parathyroid imaging: a systematic review |
10 |
| Practical guidelines for the use of technetium-99m mebrofenin hepatobiliary scintigraphy in the quantitative assessment of liver function |
9 |
| Importance of F-18-FDG PET/CT to select patients with nonresectable colorectal liver metastases for liver transplantation |
9 |
| The efficacy of fluorine-18-choline PET/CT in comparison with Tc-99m-MIBI SPECT/CT in the localization of a hyperfunctioning parathyroid gland in primary hyperparathyroidism |
7 |
| Intratumoral injection of radioactive holmium-166 microspheres in recurrent head and neck squamous cell carcinoma: preliminary results of first use |
7 |
| Comparison of F-18-Fluciclovine PET/CT and Tc-99m-MDP bone scan in detection of bone metastasis in prostate cancer |
7 |
| Prognostic factor analysis in 325 patients with Graves' disease treated with radioiodine therapy |
6 |
| Dosimetry-based treatment for Graves' disease |
6 |
| Clinical and prognostic value of F-18-FDG-PET/CT in restaging of pancreatic cancer |
5 |
| Classification of amyloid PET images using novel features for early diagnosis of Alzheimer's disease and mild cognitive impairment conversion |
5 |
| F-18-FDG PET/CT versus conventional investigations for cancer screening in autoimmune inflammatory myopathy in the era of novel myopathy classifications |
5 |
| Role of F-18-FDG PET/CT in evaluating molecular subtypes and clinicopathological features of primary breast cancer |
5 |
| Clinical impact of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in patients with resectable pancreatic cancer: diagnosing lymph node metastasis and predicting survival |
5 |
| Assessment of biological and clinical aggressiveness of invasive ductal breast cancer using baseline F-18-FDG PET/CT-derived volumetric parameters |
5 |
| Diastolic dysfunction can precede systolic dysfunction on MUGA in cancer patients receiving trastuzumab-based therapy |
5 |
| Assessing EGFR gene mutation status in non-small cell lung cancer with imaging features from PET/CT |
5 |
| Diagnostic value of F-18-FDG PET/MRI in recurrent pelvis malignancies of female patients: a systematic review and meta-analysis |
4 |
| An update on dose calibrator' settings for nuclides used in nuclear medicine |
4 |
| Quantitative evaluation of normal spinal osseous metabolism with F-18-NaF PET/CT |
4 |
| Clinical outcomes and prognostic factors of radioiodine ablation therapy for lymph node metastases from papillary thyroid carcinoma |
4 |
| Correlation between functional imaging markers derived from diffusion-weighted MRI and F-18-FDG PET/CT in esophageal cancer |
4 |
| Comparison between technetium-99m methoxyisobutylisonitrile scintigraphy and ultrasound in the diagnosis of parathyroid adenoma and parathyroid hyperplasia |
4 |
| Hypoxia imaging with [F-18]HX4 PET in squamous cell head and neck cancers: a pilot study for integration into treatment planning |
4 |
| Propagation of measurement errors in glomerular filtration rate determination: a comparison of slope-intercept, single-sample and slope-only methods |
4 |
| Resistant functioning and/or progressive symptomatic metastatic gastroenteropancreatic neuroendocrine tumors: efficacy of Lu-177-DOTATATE peptide receptor radionuclide therapy in this setting |
4 |
| Dual-time F-18-FDG PET/CT for the detection of liver metastases in breast cancer |
4 |
| Investigating the histopathologic correlates of F-18-FDG PET heterogeneity in non-small-cell lung cancer |
4 |
| Gallium-68 DOTA-NOC PET/CT as an alternate predictor of disease activity in sarcoidosis |
4 |
| Usefulness of the combination of iodine-123-metaiodobenzylguanidine scintigraphy and iodine-123-ioflupane scintigraphy in new-onset Parkinson's disease |
4 |
| Gallium 68-PSMA PET/CT for lesion characterization in suspected cases of prostate carcinoma |
4 |
| Radioiodine remnant ablation in papillary thyroid microcarcinoma: a meta-analysis |
4 |
| Evaluating the potential of kit-based Ga-68-ubiquicidin formulation in diagnosis of infection: a pilot study(68)Ga |
4 |
| Validation of quantitative salivary gland scintigraphy in relation to the American-European concensus criteria for Sjogren's syndrome |
3 |
| Prognostic value of F-18-FDG PET/CT functional parameters in patients with head and neck cancer: a meta-analysis |
3 |
| Assessment of the role of early dynamic PET/CT with F-18-fluorocholine in detection of parathyroid lesions in patients with primary hyperparathyroidism |
3 |
| Comparison of (F-18)FDG PET/CT and (Ga-68)DOTATATE PET/CT imaging methods in terms of detection of histological subtype and related SUVmax values in patients with pulmonary carcinoid tumors |
3 |
| Quantitative PET/CT in clinical practice: assessing the agreement of PET tumor indices using different clinical reading platforms |
3 |
| Myocardial stunning-induced left ventricular dyssynchrony on gated single-photon emission computed tomography myocardial perfusion imaging |
3 |
| Tissue standardized uptake value is a closer surrogate of blood fluorine-18 fluorodeoxyglucose clearance after division by blood standardized uptake value, illustrated in brain and liver |
3 |
| Ga-68-PSMA-HBED-CC PET/CT imaging in Black versus White South African patients with prostate carcinoma presenting with a low volume, androgen-dependent biochemical recurrence: a prospective study |
3 |
| Validation of prognostic biomarker scores for predicting progression of dementia in patients with amnestic mild cognitive impairment |
3 |
| Indirect assessment of the maximum empirical activity (250 mCi) with respect to dosimetry concepts in radioiodine therapy of metastatic differentiated thyroid cancer |
3 |
| Evaluation of the most commonly used (semi-) quantitative parameters of F-18-FDG PET/CT to detect malignant transformation of neurofibromas in neurofibromatosis type 1 |
3 |
| Comparison between visual and numerical metrics for the evaluation of patients with Takayasu arteritis with F-18-FDG-PET |
3 |
| The value of whole-body contrast-enhanced F-18-FDG PET/CT imaging in the diagnosis and staging of patients with laryngeal carcinoma |
3 |
| History and development of radioembolization: an old idea with modern applications |
3 |
